We’re at the Dawn of the Ozempic Era — and It’s Really Weird
177 claims analyzed
Claims177
A Kaiser Family Foundation poll found that one in eight Americans is currently taking a GLP-1 drug.
France has used land-use planning since the late 1800s to minimize grocery-store size.
Childhood diabetes is caused by the food environment.
GLP-1 drugs rival bariatric surgery as a medical intervention for weight loss.
GLP-1 drugs are synthetic versions of a hormone the body produces naturally.
People have to stay on GLP-1 drugs to keep the weight-loss benefits.
People with diabetes have to keep taking insulin.
Statins reduce cardiovascular risk by about 29%.
The sleep-apnea benefit of GLP-1 drugs depends on weight loss.
Dan Drucker helped discover the GLP-1 drug class.
In a Times survey, 63% of GLP-1 users said they would want to stay on the drug even if it did not work for weight loss.
Long-term data are lacking for tirzepatide.
Most Americans do not get enough sleep.
A compound used in explosives manufacturing after World War I caused people to lose weight.
The New Yorker tested peptides sold online and found that many contained lead.
The New Yorker tested peptides sold online and found that many were not at the right dose.
Television ads with famous actors opposed increased FDA regulation of dietary supplements.
California is considering reducing ultra-processed foods in school lunches.
West Virginia is considering reducing ultra-processed foods in school lunches.
GLP-1 drugs affect addiction.
GLP-1 weight-loss drugs do not increase energy burn.
Hungry rodents are more likely to exhibit addictive behaviors.
The New Yorker tested peptides sold online and found that many contained impurities.
Representatives from states with large supplement manufacturers pushed for a lax regulatory environment for dietary supplements.
Childhood fatty liver disease is caused by the food environment.
France has fresh food markets in every district.
Food producers in the United States once used brick dust to dye food.
GLP-1 drugs protect kidney health.
GLP-1 drugs are protective of kidneys.
GLP-1 drugs are protective of livers.
GLP-1 drugs protect liver health.
The United States has a relatively unrestricted approach to pharmaceutical marketing.
The telemedicine industry has flourished since COVID.
GLP-1 is produced to a lesser extent in the pancreas.
Some GLP-1 weight-loss drugs produce about 15 percent weight loss.
Stimulating the brain GLP-1 system is necessary to get the weight-loss effects of GLP-1 drugs.
GLP-1 drugs have to reach the brain to affect appetite.
One theory is that GLP-1 drugs activate a brain area that signals toxins in circulation.
Activation of that brain region shuts down appetite.
Almost all genetic variants associated with common obesity act in the brain.
The genetic variants associated with common obesity almost all act in the brain.
Sleep deprivation makes people eat more.
Vomiting is one of the most common known side effects of GLP-1 drugs.
Diarrhea is one of the most common known side effects of GLP-1 drugs.
There is no screening yet for eating disorders in young people before prescribing GLP-1 drugs.
There is no screening for eating disorders in young people receiving GLP-1 drugs.
People with obesity face a pay penalty.
About 1% of children eligible for GLP-1 obesity medications are currently taking GLP-1 drugs.
A study found large drops in mortality from cardiac events among GLP-1 drug users.
The cardiac mortality drops seen in a GLP-1 drug study did not appear to depend on weight loss.
More benefits researchers are discovering from GLP-1 drugs appear to be independent of weight loss.
Some people obtain GLP-1-related research chemicals through TikTok influencers.
Some people taking GLP-1 drugs report anhedonia.
Clinical trials of GLP-1 drugs for addictive behaviors have had mixed results.
Doctors at Stanford turned an explosives-manufacturing ingredient into a weight-loss drug.
Michael Bloomberg wanted to tax sodas in New York.
West Virginia is considering banning certain food additives.
California is considering banning certain food additives.
GLP-1 drugs appear to protect heart health independent of weight loss.
GLP-1 drugs protect heart health independently of weight loss.
Research is ongoing into GLP-1 drugs for Alzheimer's disease.
There is ongoing research on GLP-1 drugs and dementia.
There is ongoing research on GLP-1 drugs and Alzheimer's disease.
Research is ongoing into GLP-1 drugs for dementia.
GLP-1 drugs were originally approved for diabetes.
Diabetes can cause limb amputation.
Diabetes can cause blindness.
The human body naturally produces GLP-1.
GLP-1 is produced in the gut.
GLP-1 is produced in the brain.
GLP-1 drugs stimulate the pancreas to release insulin only when blood sugar is high.
Insulin therapy can put patients at risk of very low blood sugar levels.
Taking insulin can put patients at risk of very low blood sugar levels.
Tirzepatide has more mechanisms of action than Wegovy.
Tirzepatide is marketed under the name Zepbound.
People taking GLP-1 drugs lose about 15 percent of body weight depending on the drug.
GLP-1 drugs produce weight loss by reducing appetite.
GLP-1 drugs do not produce weight loss by increasing energy burn.
GLP-1 is released after eating.
GLP-1 helps signal satiety.
Activation of that brain region increases nausea.
GLP-1 acts as a neurotransmitter in the brain.
Most people with obesity have common obesity.
Common obesity arises from more than 1,000 genetic variants.
Not sleeping enough makes people eat more.
For people who lose weight effectively on GLP-1 drugs, cravings can change.
Many GLP-1 users report that food noise disappears.
Some people are sensitive to GLP-1 drugs while others are insensitive.
In studies, people often do not stay on GLP-1 drugs for long.
Some people stop taking GLP-1 drugs because of cost.
Nausea is one of the most common side effects of GLP-1 drugs.
Some lawsuits over GLP-1 drugs concern severe stomach problems.
Lawsuits allege that GLP-1 drugs can cause severe stomach problems.
Some lawsuits over GLP-1 drugs concern ocular nerve damage.
Lawsuits allege that GLP-1 drugs can cause damage to the ocular nerve.
The GLP-1 lawsuits allege that people were not properly warned about potential side effects.
People tend to regain weight after stopping GLP-1 drugs.
The appetite-suppressing effect of GLP-1 drugs disappears after stopping the drugs.
The therapeutic effect of statins goes away when patients stop taking statins.
Pediatricians prescribe GLP-1 drugs to children.
People with obesity face discrimination.
People with obesity face stigma.
At the population level, higher BMI is associated with higher health risks.
Ozempic came onto the market as a diabetes treatment.
Participants in diabetes trials of GLP-1 drugs started losing weight as doses increased.
Companies are required to examine cardiovascular-event risks for new diabetes drugs.
Fen-Phen increased the risk of cardiovascular events.
A cardiovascular outcomes trial of a GLP-1 drug found a 20% reduction in cardiovascular risk.
Observational studies show that people taking GLP-1 drugs have much lower dementia risk.
A randomized controlled trial found that GLP-1 drugs did not improve outcomes for people with Alzheimer's disease.
A GLP-1-related drug is approved to treat sleep apnea.
GLP-1 drugs appear to lower inflammation.
Mice and cell research has suggested that GLP-1 drugs could benefit post-concussion syndrome.
No randomized controlled trial has tested GLP-1 drugs for post-concussion syndrome.
Some people obtain GLP-1 drugs through low-barrier telemedicine prescriptions.
Oral forms of GLP-1 drugs are now available.
Some GLP-1 drugs are going generic.
Retatrutide is an Eli Lilly drug.
Eli Lilly makes Zepbound.
Retatrutide is in clinical trials.
Retatrutide is a research compound still under study.
Retatrutide targets three hormone receptors.
Semaglutide targets one hormone receptor.
Tirzepatide targets more than just the GLP-1 receptor.
Long-term data are lacking for retatrutide.
Retatrutide causes faster and more dramatic weight loss in research so far.
Retatrutide appears to increase energy use.
FDA approval of retatrutide requires randomized controlled trials.
Some people are buying retatrutide from illicit sources before FDA approval.
Most Americans do not meet the minimum daily recommended intake of fruits and vegetables.
Most Americans do not get enough physical activity.
India is the biggest adopter of cryptocurrency globally.
Estonia offers online voting in all of its elections.
A compound used in explosives manufacturing after World War I sped up metabolism.
An explosives-derived weight-loss drug was taken by hundreds of thousands of people.
An explosives-derived weight-loss drug became one of the FDA's first targets.
An explosives-derived weight-loss drug killed people through side effects.
An explosives-derived weight-loss drug caused eye problems.
Supplement makers helped mount a major campaign against stricter FDA regulation of dietary supplements.
A public letter-writing campaign opposed increased FDA regulation of dietary supplements.
Fen-Phen was a once-popular diet drug that later proved harmful.
Coca-Cola used to contain cocaine.
The long-term effects of GLP-1 drugs in young people are not understood.
The number of children with diabetes is increasing.
The number of children with fatty liver disease is increasing.
Robert F. Kennedy Jr. is the secretary of Health and Human Services.
France uses school lunches as a policy lever to feed children healthfully.
The United States began protecting people against acute food poisoning more than 100 years ago.
Food producers in the United States once put calf brains in milk.
Food producers in the United States once put lead in food.
The FDA originated from U.S. efforts to protect consumers from adulterated food.
The USDA meat inspection program came after the publication of Upton Sinclair's book.
Programs that made local and fresh produce available for school lunches have been cut.